Affiliation:
1. Microbiology Department, Glaxo Research Ltd., Greenford, Middlesex UB6 OHE, England
Abstract
The degree of peptidoglycan cross-linking has been studied in growing cells of a Dap
−
Lys
−
auxotroph of
Escherichia coli
K-12 by following the incorporation of [
3
H]diaminopimelic acid into the lysozyme digestion products of crude, isolated peptidoglycan. The percentage of inhibition of cross-linking increases with increasing concentrations of penicillin G, cephaloridine, and cefuroxime. When the R factor R1
drd
19 was introduced into the strain by conjugation, it was found that the type IIIa, β-lactamase specified by the plasmid was able to protect the cross-linking target against inhibition by penicillin G but not against cephaloridine, even though the β-lactamase hydrolyzes this substrate 50% faster than penicillin G. Cefuroxime, which is completely resistant to hydrolysis by the type IIIa β-lactamase, inhibited the peptidoglycan cross-linking target in both the R
+
and R
−
variants of the assay strain. A mutant plasmid, R1
drd
19
amp
2, which specified no type IIIa β-lactamase synthesis, could not provide protection of the cross-linking target against penicillin G. The significance of these results, in relation to the ability of the antibiotics to pass the permeability barrier of the bacterial envelope, is discussed.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献